Christopher Moxham - Insider Trading & Ownership

Entity
Individual
Location
26 Landsdowne Street, Cambridge, MA
Summary
The estimated net worth of Christopher Moxham is at least $103K dollars as of August 12, 2021. Christopher Moxham is the Chief Scientific Officer of Fulcrum Therapeutics, Inc. and owns shares of Fulcrum Therapeutics, Inc. (FULC) stock worth about $103K.
All Insider Reports
All Insider Reports

Ownership of Christopher Moxham

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
FULC Fulcrum Therapeutics, Inc. Chief Scientific Officer $103K Aug 10, 2021

Insider Transactions Reported by Christopher Moxham:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.